68210-4164-1 : NDC 2026 Code

68210-4164-1 : Acetaminophen, Guaifenesin And Phenylephrine Hcl ( Non-drowsy Daytime Severe Sinus Congestion And Pain )

Additionally :

You can get information about “68210-4164-1” NDC code in 68210-4164-1 in HTML format

HTML | 68210-4164-1 in TXT (Plain Text) format

TXT | 68210-4164-1 in PDF (Portable Document Format)

PDF | 68210-4164-1 in XML format

XML formats.

NDC Code : 68210-4164-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68210-4164-1",
    "PackageDescription": "1 BOTTLE in 1 CARTON (68210-4164-1)  / 12 TABLET, FILM COATED in 1 BOTTLE",
    "NDC11Code": "68210-4164-01",
    "ProductNDC": "68210-4164",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Non-drowsy Daytime Severe Sinus Congestion And Pain",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen, Guaifenesin And Phenylephrine Hcl",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210623",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "Spirit Pharmaceuticals LLC",
    "SubstanceName": "ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE",
    "StrengthNumber": "325; 200; 5",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2026-01-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20210623",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}